References
- Pazar B, Gergely Jr P, Nagy Z, et al. Role of HLA-DRB1 and PTPN22 genes in susceptibility to juvenile idiopathic arthritis in Hungarian patients. Clin Exp Rheumatol. 2008;26(6):1146–1152.
- Hinks A, Barton A, Shephard N, et al. Identification of a novel susceptibility locus for juvenile idiopathic arthritis by genome-wide association analysis. Arthr Rheum. 2009;60(1):258–263.
- Bowyer S, Roettcher P. Pediatric rheumatology clinic populations in the United States: results of a 3 source survey. Pediatric Rheumatology Database Research Group. J Rheumatol. 1996;23(11):1968–1974.
- Thompson SD, Sudman M, Ramos PS, et al. The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Arthr Rheum. 2010;62(11):3265–3276.
- Huang J-L. New advances in juvenile idiopathic arthritis. Chang Gung Med J. 2012;35(1):1–14.
- Viken M, Amundsen S, Kvien T, et al. Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun. 2005;6(3):271–273.
- Hinks A, Eyre S, Ke X, et al. Overlap of disease susceptibility loci for rheumatoid arthritis and juvenile idiopathic arthritis. Ann Rheum Dis. 2010;69(6):1049–1053.
- Angeles-Han S, Prahalad S. The genetics of juvenile idiopathic arthritis: What is new in 2010? Curr Rheumatol Rep. 2010;12(2):87–93.
- Prahalad S, Hansen S, Whiting A, et al. Variants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis. Arthr Rheum. 2009;60(7):2124–2130.
- Maddah M, Harsini S, Rezaei A, et al. Association of Interleukin-2, but not Interferon-Gamma, single nucleotide polymorphisms with juvenile idiopathic arthritis. Allergol Immunopathol. 2016;44:303–306.
- Hersh AO, Prahalad S. Immunogenetics of juvenile idiopathic arthritis: A comprehensive review. J Autoimmun. 2015;64:113–124.
- Cohen S, Dadi H, Shaoul E, et al. Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp. Blood 1999;93(6):2013–2024.
- Lee Y, Rho Y, Choi S, et al. The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology 2007;46(1):49–56.
- Horie Y, Kitaichi N, Katsuyama Y, et al. Evaluation of PTPN22 polymorphisms and Vogt–Koyanagi–Harada disease in Japanese patients. Mol Vis. 2009;15:1115–1119.
- Hasegawa K, Martin F, Huang G, et al. PEST domain-enriched tyrosine phosphatase (PEP) regulation of effector/memory T cells. Science 2004;303(5658):685–689.
- Gregersen PK, Olsson LM. Recent advances in the Genetics of autoimmune disease. Ann Rev Immunol. 2009;27:363–391.
- Yamada R, Yamamoto K. Mechanisms of disease: Genetics of rheumatoid arthritis—ethnic differences in disease-associated genes. Nat Clin Pract Rheumatol. 2007;3(11):644–650.
- Ladner MB, Bottini N, Valdes AM, Noble JA. Association of the single nucleotide polymorphism C1858T of the PTPN22 gene with type 1 diabetes. Hum Immunol. 2005;66(1):60–64.
- Criswell LA, Pfeiffer KA, Lum RF, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: The PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005;76(4):561–571.
- Kyogoku C, Ortmann WA, Lee A, et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am J Hum Genet. 2004;75(3):504–507.
- Lee A, Li W, Liew A, et al. The PTPN22 R620W polymorphism associates with RF positive rheumatoid arthritis in a dose-dependent manner but not with HLA-SE status. Genes Immun. 2005;6(2):129–133.
- Smyth D, Cooper JD, Collins JE, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004;53(11):3020–3023.
- Canton I, Akhtar S, Gavalas N, et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun. 2005;6(7):584–587.
- Skórka A, Bednarczuk T, Bar-Andziak E, et al. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: Association and gene dose-dependent correlation with age of onset. Clin Endocrinol. 2005;62(6):679–682.
- Kawasaki E, Awata T, Ikegami H, et al. Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22): association between a promoter polymorphism and type 1 diabetes in Asian populations. Am J Med Genet Part A. 2006;140(6):586–593.
- Carlton VE, Hu X, Chokkalingam AP, et al. PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am J Hum Genet. 2005;77(4):567–581.
- Tang L, Wang Y, Zheng S, et al. PTPN22 polymorphisms, but not R620W, were associated with the genetic susceptibility of systemic lupus erythematosus and rheumatoid arthritis in a Chinese Han population. Hum Immunol. 2016;77:692–698.
- Rodríguez-Rodríguez L, Taib WRW, Topless R, et al. The PTPN22 R263Q polymorphism is a risk factor for rheumatoid arthritis in Caucasian case-control samples. Arthr Rheum. 2011;63(2):365–372.
- Roe BA, Crabtree JS, Khan AS, et al. DNA isolation and sequencing. Hoboken, NJ: John Wiley & Sons; 1996.
- Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc Ser B (Methodolog) 1995;57:289–300.
- Moncrieffe H, Prahalad S, Thompson SD. Genetics of juvenile idiopathic arthritis: new tools bring new approaches. Curr Opin Rheumatol. 2014;26(5):579–584.
- Farivar S, Shiari R, Hadi E. Genetic susceptibility to juvenile idiopathic arthritis in Iranian children. Arch Med Res. 2011;42(4):301–304.
- Hinks A, Barton A, John S, et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: Further support that PTPN22 is an autoimmunity gene. Arthr Rheum. 2005;52(6):1694–1699.
- Mahmoudi M, Rezaiemanesh A, Salmaninejad A, et al. PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus. Autoimmunity 2015;48(7):488–493.
- Ban Y, Tozaki T, Taniyama M, et al. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid. 2010;20(8):893–899.
- Taniyama M, Maruyama T, Tozaki T, et al.. Association of PTPN22 haplotypes with type 1 diabetes in the Japanese population. Hum Immunol. 2010;71(8):795–798.
- Tan RJ, Gibbons LJ, Potter C, et al. Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment. Ann Rheum Dis. 2010;69(6):1029–1035.
- Dimopoulou D, Zervou M, Trachana M, et al. Investigation of juvenile idiopathic arthritis susceptibility loci: Results from a Greek population. Hum Immunol. 2013;74(9):1194–1198.
- Cinek O, Hradsky O, Ahmedov G, et al. No independent role of the −1123 G>C and + 2740 A>G variants in the association of PTPN22 with type 1 diabetes and juvenile idiopathic arthritis in two Caucasian populations. Diab Res Clin Pract. 2007;76(2):297–303.